| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 3, 1458-1466, Copyright © 1993 by American Society of Nephrology
REGULAR ARTICLES |
V Gambara, G Mecca, G Remuzzi and T Bertani
Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
The nature of renal damage in patients with type II diabetes remains unclear. This study was directed to evaluate pathologic changes in 52 patients affected by type II diabetes with overt clinical nephropathy by conventional and morphometric techniques. The duration of diabetes ranged from 6 to 384 months, urinary protein excretion ranged from 0.9 to 9.2 g/24 h, and serum creatinine ranged from 0.9 to 9 mg/dL. Specimens were examined semiquantitatively by light microscopy, immunofluorescence, and electron microscopy. Glomerular tuft cross- sectional area was measured by a versatile computer system. Pathologic examination revealed three distinct patterns arbitrarily defined as Classes 1, 2, and 3. Class 1 included 19 patients with typical changes of diabetic nephropathy characterized by a high score of glomerulosclerosis (mean score, 2.1), marked glomerular hypertrophy (23,632 microns2), and arteriolar hyalinosis (mean score, 2). There was a positive correlation between glomerulosclerosis and arteriolar hyalinosis scores (P < 0.05). Class 2 included 16 patients showing chronic and aspecific changes. As compared with Class 1 patients, these patients had less glomerulosclerosis (mean score, 1.3) and less arteriolar hyalinosis (mean score, 0.8) but more severe ischemic glomerular lesions (mean score, 1.4) and arteriosclerosis (mean score, 2). Class 3 included 17 patients showing glomerular disease superimposed on diabetic glomerulosclerosis. There were no differences in age, mean duration of diabetes, renal function, urinary protein excretion, and mean arterial pressure among the three classes of patients. This study indicates that renal lesions in patients with type II diabetes manifest in a quite heterogeneous fashion.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
K. Hamano, A. Nitta, T. Ohtake, and S. Kobayashi Associations of Renal Vascular Resistance With Albuminuria and Other Macroangiopathy in Type 2 Diabetic Patients Diabetes Care, September 1, 2008; 31(9): 1853 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Kramer, C. B. Leitao, L. C. Pinto, S. P. Silveiro, J. L. Gross, and L. H. Canani Clinical and Laboratory Profile of Patients With Type 2 Diabetes With Low Glomerular Filtration Rate and Normoalbuminuria Diabetes Care, August 1, 2007; 30(8): 1998 - 2000. [Full Text] [PDF] |
||||
![]() |
J.-J. Kim, J. J. Li, D.-S. Jung, S.-J. Kwak, D.-R. Ryu, T.-H. Yoo, S. H. Han, H. Y. Choi, H. J. Kim, D. S. Han, et al. Differential Expression of Nephrin According to Glomerular Size in Early Diabetic Kidney Disease J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2303 - 2310. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. MacIsaac, S. Panagiotopoulos, K. J. McNeil, T. J. Smith, C. Tsalamandris, H. Hao, P. G. Matthews, M. C. Thomas, D. A. Power, and G. Jerums Is Nonalbuminuric Renal Insufficiency in Type 2 Diabetes Related to an Increase in Intrarenal Vascular Disease? Diabetes Care, July 1, 2006; 29(7): 1560 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Caramori, P. Fioretto, and M. Mauer Enhancing the Predictive Value of Urinary Albumin for Diabetic Nephropathy J. Am. Soc. Nephrol., February 1, 2006; 17(2): 339 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kramer and M. E. Molitch Screening for Kidney Disease in Adults With Diabetes Diabetes Care, July 1, 2005; 28(7): 1813 - 1816. [Full Text] [PDF] |
||||
![]() |
R.J. MacIsaac, C. Tsalamandris, S. Panagiotopoulos, T.J. Smith, K.J. McNeill, G. Jerums, X Bai, D. Miao, J. Li, D. Goltzman, et al. Type 2 Diabetes: Absence of Proteinuria Does Not Preclude Loss of Renal Function: Nonalbuminuric Renal Insufficiency in Type 2 Diabetes. Diabetes Care 27: 195-200, 2004 J. Am. Soc. Nephrol., February 1, 2005; 16(2): 284 - 290. [Full Text] [PDF] |
||||
![]() |
H.-L. Zhao, P. C.Y. Tong, F. M.M. Lai, B. Tomlinson, and J. C.N. Chan Association of Glomerulopathy With the 5'-End Polymorphism of the Aldose Reductase Gene and Renal Insufficiency in Type 2 Diabetic Patients Diabetes, November 1, 2004; 53(11): 2984 - 2991. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. MacIsaac, C. Tsalamandris, S. Panagiotopoulos, T. J. Smith, K. J. McNeil, and G. Jerums Nonalbuminuric Renal Insufficiency in Type 2 Diabetes Diabetes Care, January 1, 2004; 27(1): 195 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dalla Vestra, A. Masiero, A. M. Roiter, A. Saller, G. Crepaldi, and P. Fioretto Is Podocyte Injury Relevant in Diabetic Nephropathy?: Studies in Patients With Type 2 Diabetes Diabetes, April 1, 2003; 52(4): 1031 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Goto, K. A. Brensing, P. Raab, U. Frotscher, G. Remuzzi, A. Schieppati, and P. Ruggenenti Diabetic Nephropathy N. Engl. J. Med., September 19, 2002; 347(12): 947 - 948. [Full Text] [PDF] |
||||
![]() |
T. Y. H. Wong, P. C. L. Choi, C. C. Szeto, K. F. To, N. L. S. Tang, A. W. H. Chan, P. K. T. Li, and F. M.-M. Lai Renal Outcome in Type 2 Diabetic Patients With or Without Coexisting Nondiabetic Nephropathies Diabetes Care, May 1, 2002; 25(5): 900 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Solini, M. Dalla Vestra, A. Saller, R. Nosadini, G. Crepaldi, and P. Fioretto The Angiotensin-Converting Enzyme DD Genotype Is Associated With Glomerulopathy Lesions in Type 2 Diabetes Diabetes, January 1, 2002; 51(1): 251 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ruggenenti and G. Remuzzi Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment? Nephrol. Dial. Transplant., December 1, 2000; 15(12): 1900 - 1902. [Full Text] [PDF] |
||||
![]() |
K. E. WHITE and R. W. BILOUS Type 2 Diabetic Patients with Nephropathy Show Structural--Functional Relationships that Are Similar to Type 1 Disease J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1667 - 1673. [Abstract] [Full Text] |
||||
![]() |
D. A. PRICE, L. E. PORTER, M. GORDON, N. D. L. FISHER, J. M. F. DE'OLIVEIRA, L. M. B. LAFFEL, D. R. PASSAN, G. H. WILLIAMS, and N. K. HOLLENBERG The Paradox of the Low-Renin State in Diabetic Nephropathy J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2382 - 2391. [Abstract] [Full Text] |
||||
![]() |
S. Olsen Identification of non-diabetic glomerular disease in renal biopsies from diabetics—a dilemma Nephrol. Dial. Transplant., August 1, 1999; 14(8): 1846 - 1849. [Full Text] [PDF] |
||||
![]() |
D. J. CORDONNIER, N. PINEL, C. BARRO, C. MAYNARD, P. ZAOUI, S. HALIMI, B. H. DE LIGNY, Y. REZNIC, D. SIMON, and R. W. BILOUS Expansion of Cortical Interstitium Is Limited by Converting Enzyme Inhibition in Type 2 Diabetic Patients with Glomerulosclerosis J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1253 - 1263. [Abstract] [Full Text] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673